American Vanguard Corp (AVD) stock
AVDNYSEAgricultural ChemicalsFiscal year ends December 31
$0.88−0.03 (-2.81%)
Close on Nov 13, 2026Market cap $25.00MP/E –Yield –
American Vanguard r&d expenses
Research and development expenses are spending on new products and technology.
American Vanguard's R&D Expenses for the twelve months ending Sep 30, 2026 was $23.12M, down 4.9% year over year. For fiscal 2025 it was $23.16M, down 29.1% from the year before. Over ten years it grew 1.9% a year on average. The highest annual figure on record is $38.03M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.16M | -29.1% |
| FY2024 | Dec 31, 2024 | $32.66M | -14.1% |
| FY2023 | Dec 31, 2023 | $38.03M | +19.5% |
| FY2022 | Dec 31, 2022 | $31.82M | +10.3% |
| FY2021 | Dec 31, 2021 | $28.86M | +9.7% |
| FY2020 | Dec 31, 2020 | $26.31M | +9.3% |
| FY2019 | Dec 31, 2019 | $24.07M | -8.9% |
| FY2018 | Dec 31, 2018 | $26.43M | +1.3% |
| FY2017 | Dec 31, 2017 | $26.08M | +22.4% |
| FY2016 | Dec 31, 2016 | $21.30M | +11.4% |
| FY2015 | Dec 31, 2015 | $19.12M | -9.9% |
| FY2014 | Dec 31, 2014 | $21.21M | -2.0% |
| FY2013 | Dec 31, 2013 | $21.64M | +4.3% |
| FY2012 | Dec 31, 2012 | $20.75M | +15.0% |
| FY2011 | Dec 31, 2011 | $18.04M | +42.8% |
| FY2010 | Dec 31, 2010 | $12.64M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $5.34M | -5.5% |
| Q2 FY2026 | Jun 30, 2026 | $6.48M | +11.7% |
| Q1 FY2026 | Mar 31, 2026 | $5.27M | -7.2% |
| Q4 FY2025 | Dec 31, 2025 | $6.02M | -16.1% |
| Q3 FY2025 | Sep 30, 2025 | $5.65M | -49.4% |
| Q2 FY2025 | Jun 30, 2025 | $5.80M | -32.5% |
| Q1 FY2025 | Mar 31, 2025 | $5.68M | -0.4% |
| Q4 FY2024 | Dec 31, 2024 | $7.18M | -32.7% |
| Q3 FY2024 | Sep 30, 2024 | $11.18M | +23.1% |
| Q2 FY2024 | Jun 30, 2024 | $8.60M | -8.6% |
| Q1 FY2024 | Mar 31, 2024 | $5.71M | -35.7% |
| Q4 FY2023 | Dec 31, 2023 | $10.66M | – |
| Q3 FY2023 | Sep 30, 2023 | $9.08M | – |
| Q2 FY2023 | Jun 30, 2023 | $9.41M | – |
| Q1 FY2023 | Mar 31, 2023 | $8.87M | – |
See a number that looks wrong?